APA (7th ed.) Citation

McGirr, A. A., Schwartz, K. L., Allen, U., Solomon, M., & Sander, B. (2017). The cost-effectiveness of palivizumab in infants with cystic fibrosis in the Canadian setting: A decision analysis model. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

McGirr, Ashleigh A., Kevin L. Schwartz, Upton Allen, Melinda Solomon, and Beate Sander. The Cost-effectiveness of Palivizumab in Infants with Cystic Fibrosis in the Canadian Setting: A Decision Analysis Model. Taylor & Francis Group, 2017.

MLA (9th ed.) Citation

McGirr, Ashleigh A., et al. The Cost-effectiveness of Palivizumab in Infants with Cystic Fibrosis in the Canadian Setting: A Decision Analysis Model. Taylor & Francis Group, 2017.